Post by Novartis US
237,383 followers
At the European Academy of Allergy and Clinical Immunology - EAACI Congress 2026, Novartis is presenting new data in chronic inducible urticaria (CIndU)—a form of chronic hives caused by a specific trigger. We are advancing bold science that may help improve understanding of chronic hives and support those living with this challenging condition. #EAACI2026
Video Content